Reading the brain’s signals to speed better treatments for Angelman syndrome
FAST-funded research identifies peak alpha frequency, an EEG biomarker that could reveal early brain responses to Angelman syndrome treatment before day-to-day changes appear.
FAST Spain Awards First Research Grant
FAST Spain awards its first research grant to study two novel biomarkers—the endocannabinoid system and transcriptomic profile—to better track Angelman syndrome progression and treatment.